In view of the limited number of investigations of β-glucan in a well-established NASH model, more animal studies with a specific focus on NASH prevention or treatment are still needed to assess the anti-inflammatory activity and its mechanism of β-glucan. The gene discussed is PPIB; the disease is metabolic dysfunction-associated steatohepatitis.